Scientists track dengue vaccine safety for moms and newborns
NCT ID NCT04486638
Summary
This study aims to monitor the safety of the Dengvaxia dengue vaccine in pregnant women and their children. It will follow about 500 women in the US who received the vaccine while pregnant, tracking their health and their baby's health for up to one year after birth. The goal is to gather information on any health issues that occur in the mother or child to better understand the vaccine's safety during pregnancy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigational Site
RECRUITINGSan Juan, Puerto Rico
Conditions
Explore the condition pages connected to this study.